PureTech Health plc (LON:PRTC)
London · Delayed Price · Currency is GBP · Price in GBX 114.20
+0.40 (0.35%)
Oct 15, 2026, 2:24 PM GMT
PureTech Health Market Cap
PureTech Health has a market cap or net worth of 280 million as of October 14, 2026. It is the 16,856th most valuable company in the world and the 360th biggest in the United Kingdom. Its market cap has decreased by 11.70% in one year.
Market Cap
280.00M
Enterprise Value
268.29M
Revenue
4.80M
Global Rank
Country Rank
#360 United Kingdom
PE Ratio
193.48
ChartMarket Cap Chart
Since June 19, 2015, PureTech Health's market cap has decreased from 404.50M to 280.00M, a decrease of -30.78%. That is a compound annual growth rate of -3.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 280.00M | -7.32% |
| Dec 31, 2025 | 302.11M | -15.99% |
| Dec 31, 2024 | 359.61M | -31.88% |
| Dec 29, 2023 | 527.94M | -28.89% |
| Dec 30, 2022 | 742.38M | -11.66% |
| Dec 31, 2021 | 840.37M | -26.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genus | 1.51B |
| Oxford Biomedica | 622.14M |
| Avacta Group | 309.11M |
| Scancell Holdings | 113.34M |
| 4basebio | 87.40M |
| Bioventix | 86.54M |
| Faron Pharmaceuticals Oy | 72.43M |
| Hemogenyx Pharmaceuticals | 52.36M |